Nalaganje...
A robust in vivo model for B cell precursor acute lymphoblastic leukemia
B cell precursor acute lymphoblastic leukemia (BCP ALL) is the most common malignancy in children. While treatments have improved remarkably over the past four decades, resistant disease and late effects that result from cytotoxic chemotherapy remain serious problems for individuals with BCP ALL. Im...
Shranjeno v:
| izdano v: | J Clin Invest |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588242/ https://ncbi.nlm.nih.gov/pubmed/26301807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI83799 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|